Loading...
Invion Limited
IVX.AX•ASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.10
A$0.003(3.13%)
Invion Limited (IVX.AX) Financial Performance & Income Statement Overview
Review Invion Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.00%
↓ 10.00%
Operating Income Growth
-358.13%
↓ 358.13%
Net Income Growth
-248.51%
↓ 248.51%
Operating Cash Flow Growth
-32.47%
↓ 32.47%
Operating Margin
-521.20%
↓ 521.20%
Gross Margin
-13.82%
↓ 13.82%
Net Profit Margin
-462.94%
↓ 462.94%
ROE
-49.23%
↓ 49.23%
ROIC
-58.19%
↓ 58.19%
Invion Limited (IVX.AX) Income Statement & Financial Overview
Review Invion Limited's (IVX.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.47M | $2.23M | $2.16M | $1.95M |
| Cost of Revenue | $1.11M | $1.58M | $1.43M | $1.47M |
| Gross Profit | $355958.00 | $647281.00 | $731925.00 | $474578.00 |
| Gross Profit Ratio | $0.24 | $0.29 | $0.34 | $0.24 |
| R&D Expenses | $1.11M | $1.58M | $1.43M | $1.47M |
| SG&A Expenses | $4.87M | $997577.00 | $1.19M | $979024.00 |
| Operating Expenses | $5.98M | $2.58M | $2.62M | $2.45M |
| Total Costs & Expenses | $7.09M | $2.98M | $2.98M | $2.78M |
| Interest Income | $10506.00 | $38931.00 | $32731.00 | $918.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $413205.00 | $402808.00 | $355930.00 | $327177.00 |
| EBITDA | -$4.51M | -$350296.00 | -$460920.00 | -$504445.00 |
| EBITDA Ratio | -$3.08 | -$0.16 | -$0.21 | -$0.26 |
| Operating Income | -$5.62M | -$753100.00 | -$816850.00 | -$831620.00 |
| Operating Income Ratio | -$3.83 | -$0.34 | -$0.38 | -$0.43 |
| Other Income/Expenses (Net) | $707164.00 | $38927.00 | $32732.00 | $915.00 |
| Income Before Tax | -$4.91M | -$714173.00 | -$784118.00 | -$830705.00 |
| Income Before Tax Ratio | -$3.35 | -$0.32 | -$0.36 | -$0.43 |
| Income Tax Expense | $0.00 | $2.00 | $0.00 | $3.00 |
| Net Income | -$4.91M | -$714173.00 | -$784118.00 | -$830705.00 |
| Net Income Ratio | -$3.35 | -$0.32 | -$0.36 | -$0.43 |
| EPS | -$0.001 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.001 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $6.24B | $6.42B | $6.42B | $6.42B |
| Weighted Avg Shares Outstanding (Diluted) | $6.42B | $6.42B | $6.42B | $6.42B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan